ReviewDer Pathologe2021
[EMPAIA-ecosystem for pathology diagnostics with AI assistance].
Review in Der Pathologe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Artificial intelligence in genitourinary pathology.Histopathology · 2026Review
- Joining forces for pathology diagnostics with AI assistance: The EMPAIA initiative.Journal of pathology informatics · 2024Review
- [20 years of pathology: from conventional histology to next-generation pathology].Pathologie (Heidelberg, Germany) · 2024Article
- Recommendations on compiling test datasets for evaluating artificial intelligence solutions in pathology.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022Review
- Towards a national strategy for digital pathology in Switzerland.Virchows Archiv : an international journal of pathology · 2022Article
- Pathology in the artificial intelligence era: Guiding innovation and implementation to preserve human insight.Academic pathologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Applications of deep learning and other artificial intelligence techniques play an increasing role in pathological research. In contrast to research, applications in clinical routine are rare so far, although the first certified solutions have already been established (analysis of prostate sections, ER, PR, and Her2 in breast cancer). Besides the still low use of virtual microscopy in practice, there are a number of hurdles that stand in the way of a rapid diffusion of AI applications. The EMPAIA project has a goal of removing these hurdles. The path taken to build an ecosystem for this purpose is intended to exemplify that the introduction of AI applications in image-based diagnostics is possible on a broad basis if the existing hurdles are removed in a joint, moderated process. The components of the EMPAIA ecosystem and its strategy will be described, and reference will be made to the technical solution approaches.
Indexed as
Identifiers
34919184What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.